Kane Biotech Inc.
KNE.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -56.86% | -2.46% | -42.99% | 244.41% | 37.69% |
| Total Receivables | -20.68% | -71.76% | -7.65% | -28.12% | 131.86% |
| Inventory | -6.96% | 51.19% | -0.77% | 123.81% | -58.06% |
| Prepaid Expenses | 9.34% | -4.56% | -14.40% | -28.10% | 113.91% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -31.51% | 2.66% | -31.42% | 94.21% | 26.01% |
|
|
|||||
| Total Current Assets | -31.51% | 2.66% | -31.42% | 94.21% | 26.01% |
| Net Property, Plant & Equipment | -81.76% | -3.36% | -42.60% | -0.19% | -2.80% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -5.11% | 1.64% | -2.42% | 7.54% | 4.29% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -34.77% | 1.35% | -29.59% | 45.75% | 10.60% |
|
|
|||||
| Total Accounts Payable | 72.36% | -43.07% | 16.69% | 13.99% | -4.67% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -5.01% | 116.67% | 14.41% | 17.86% | 3.12% |
| Total Finance Division Other Current Liabilities | -2.47% | -- | -- | -49.58% | 189.99% |
| Total Other Current Liabilities | -2.47% | -- | -- | -49.58% | 189.99% |
| Total Current Liabilities | 1.97% | 36.78% | -8.29% | -9.13% | -4.43% |
|
|
|||||
| Total Current Liabilities | 1.97% | 36.78% | -8.29% | -9.13% | -4.43% |
| Long-Term Debt | 1.89% | -52.32% | -5.93% | 66.86% | -9.70% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 1.78% | -49.07% | 0.89% | -3.94% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -8.63% | 0.06% | -14.48% | 9.62% | -5.57% |
|
|
|||||
| Common Stock & APIC | -1.41% | 3.27% | -1.95% | 9.20% | 5.50% |
| Retained Earnings | -0.37% | -3.11% | 0.43% | -6.42% | -3.65% |
| Treasury Stock & Other | -1.89% | 1.92% | -1.89% | 4.95% | -77.90% |
| Total Common Equity | -87.11% | 4.41% | -230.59% | 78.16% | 30.32% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -87.11% | 4.41% | -230.59% | 78.16% | 30.32% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -87.11% | 4.41% | -230.59% | 78.16% | 30.32% |
|
|
|||||